Trial Study to see the effect of Brahmi Churna and Mandukparni Churna in deficit/Hypaeractivity Disorder

A Comparative Clinical Study on Brahmi Churna and Mandukparni Churna in the management of Attention-Deficit/Hyperactivity Disorder

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/09/009595

Enrollment

Registered

2017-09-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Attention-Deficit/Hyperactivity Disorder

Interventions

Intervention1: Intervention-Brahmi Churna : Brahmi Churna-Child Dose as per age will be calculated according to Youngs Formula(3gm is the Adult Dose).Time of Administration-3 divided doses before meal

Eligibility

Inclusion criteria

Inclusion criteria: 1)Children fulfilling DSM-IV Criteria. 2)Children between 5-12years of age. 3)Children irrespective of gender,religion,socio-economic status. 4)Patientâ??s parent/legal guardian who is ready to sign Consent Form.

Exclusion criteria

Exclusion criteria: 1)Children less than 5years and more than 12years. 2)Children with Seizures. 3)Children with Systemic Illnessess. 4)Children with Chronic Infections. 5)Children with Mental Retardation.

Design outcomes

Primary

Measure	Time frame
Changes observed in Hyperactivity,inattention, impulsive behaviour.Timepoint: 45 DAYS	—

Secondary

Measure	Time frame
Observations will be noted like overall performance,comparison from before and after treatment.Timepoint: 45 DAYS	—

Countries

India

Contacts

Public ContactAMRUTA DEOKAR

GUJARAT AYURVED UNIVERSITY

dyumanpooja@yahoo.com9426761139

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026